Every pregnancy deserves next-generation care.

A sudden spike in blood pressure. A rushed trip to the hospital. A baby born weeks or months too soon.

It’s time to stop rising rates of preterm birth due to preeclampsia.

Every pregnancy deserves next-generation care.

A sudden spike in blood pressure. A rushed trip to the hospital. A baby born weeks or months too soon.

It’s time to stop rising rates of preterm birth due to preeclampsia.

KNOW RISK EARLY TO GET AHEAD OF IT

Preeclampsia is a leading cause of preterm birth.

The outdated one-size-fits-none approach leads to pregnancy care that is failing expecting mothers and their babies.

Frequently, preeclampsia is caught too late to reduce rates of preterm birth and severe complications.

Preeclampsia affects 1 in 12 pregnancies, a rate that has doubled since 2008.

Approximately 60% of cases are classified as severe preeclampsia.

Predicting preeclampsia risk is now possible.

Encompass™ is the first and only RNA-based blood test that predicts preeclampsia risk months before symptoms.

Encompass can identify 91% of preterm preeclampsia cases.

For providers

Objective risk, not maternal characteristics. Biology, not broad demographics. Proactive, tailored risk reduction.

Expectant mother with her clinician during a prenatal visit

Get ahead of preeclampsia before it surprises you.

For patients

Know your personal risk. Get clarity on the path ahead so you can have the healthiest pregnancy possible.

The next generation of pregnancy care has arrived.

Recognized as one of TIME’s Best Inventions of 2025, Encompass gives you and your care team objective data to take control before a crisis strikes. It is a highly actionable breakthrough that helps guide moms and their care teams toward the healthiest possible pregnancy.

LANDMARK RESEARCH

BREAKTHROUGH RNA-SCIENCE

Powered by the Mirvie RNA Platform for unmatched predictive insight.

"The Encompass test is harnessing new insights about the biology of preeclampsia. For pregnant patients, this test can tell them if they're at risk for preeclampsia or not and give them real biological reasons why. It can help us be informed about whether they need to take proactive precautions or not."

Dr. Dallas Reed, MD, FACOG, FACMG

OBGYN, Medical Geneticist and Chief of Genetics at Tufts Medical Center; Encompass Clinical Advisory Board Member

REFERENCES:

CDC Wonder Natality Database 2023. Accessed June 24, 2025.

Elovitz MA et al. Molecular subtyping of hypertensive disorders of pregnancy. Nature Comms (2025)

Fink DA et al. Trends in maternal mortality and severe maternal morbidity. JAMA Network Open (2023)

Roberts J et al. Care plan for individuals at risk for preeclampsia: shared approach to education, strategies for prevention, surveillance, and follow-up. Am J Obstet Gyn (2023)